pharmalittle fda - Robuta Search

https://www.statnews.com/pharmalot/2026/03/26/fda-rare-disease-pto-novo-nordisk-340b-abortion-hiv/ Pharmalittle: FDA approves rare disease drug, PTO chief grilled | STAT Mar 26, 2026 - A bipartisan quartet of senators unveiled legislation to cap the monthly cost of insulin at $35 for patients on private insurance. rare disease drug pharmalittle fda approves pto chief https://www.statnews.com/pharmalot/2026/04/01/fda-compounding-peptides-iran-war-trial-recruitment/ Pharmalittle: FDA changing view on peptides; Iran war affects trials| STAT Apr 1, 2026 - Of more than 65,000 clinical trials recruiting patients in 186 countries, nearly 7% have been affected by the Iran war. iran war affects pharmalittle fda trials stat changing view https://www.statnews.com/pharmalot/2026/04/14/fda-push-clinical-trial-transparency-novo-nordisk-openai-deal/ Pharmalittle: FDA push for trial transparency, Novo-OpenAI deal | STAT Apr 14, 2026 - AstraZeneca to require hospitals and clinics participating in a U.S. drug discount program to submit claims data for dispensing its drugs pharmalittle fda trial transparency openai deal push novo https://www.statnews.com/pharmalot/2026/04/15/fda-seeks-data-lilly-obesity-pill-pharma-win-340b-case-hiv/ Pharmalittle: FDA seeks Lilly obesity pill data, pharma gets 340B win | STAT Apr 15, 2026 - A Delaware judge threw out lawsuits seeking to link the Zantac heartburn drug to cancer, freeing drugmakers from facing trials in the state. pharmalittle fda obesity pill seeks lilly data https://www.statnews.com/pharmalot/2026/03/27/novo-nordisk-boost-consumer-focus-fda-approves-gene-therapy/ Pharmalittle: Novo boosts consumer focus, FDA okays gene therapy | STAT Mar 27, 2026 - People with pre-existing depression or anxiety were less likely to have worsening mental health while taking a GLP-1 medication. gene therapy pharmalittle novo boosts consumer https://www.statnews.com/pharmalot/2026/04/16/alzheimers-drugs-review-fda-panel-for-compounded-peptides/ Pharmalittle: Alzheimer's drugs reviewed, FDA panel to vet peptides | STAT Apr 16, 2026 - A new report released by Senate Democrats finds that prescription drug prices have continued to climb — in some cases, sharply. pharmalittle alzheimer drugs reviewed fda